A. Savas et al., Fatal toxic effect of bleomycin on brain tissue after intracystic chemotherapy for a craniopharyngioma: Case report, NEUROSURGER, 46(1), 2000, pp. 213-216
OBJECTIVE AND IMPORTANCE: Craniopharyngiomas are benign neoplasms of epithe
lial origin that arise from the remnants of Rathke's pouch and are located
in the sellar, parasellar, and third ventricular regions. Despite major adv
ances in microsurgical techniques, total removal of these tumors is associa
ted with a high risk of death, long-term endocrinological dependence, cogni
tive dysfunction, and behavioral disorders. For patients with monocystic cr
aniopharyngiomas, encouraging postoperative survival rates and high rates o
f cyst regression after intracavitary administration of bleomycin have been
reported. Moreover, only a few side effects have been reported for this tr
eatment method, We report a patient with a cystic craniopharyngioma who was
treated using intracavitary bleomycin administration and died as a result
of the direct toxic effects of bleomycin on deep brain structures and the b
rainstem,
CLINICAL PRESENTATION AND INTERVENTION: A 47-year-old woman with a cystic c
raniopharyngioma underwent stereotactic insertion of a catheter attached to
a subcutaneous reservoir. Five months after the procedure, positive-contra
st computed tomographic cystography was performed to confirm the absence of
fluid leakage. Daily intracavitary injections of bleomycin were administer
ed through the reservoir into the cyst, until a total dose of 56 mg had bee
n administered in 8 days, After the treatment, the cystic cavity regressed
but the patient exhibited neurological deterioration; magnetic resonance im
aging scans revealed diffuse edema in the diencephalon and brainstem. The p
atient died 45 days after completion of the treatment.
CONCLUSION: Intracavitary administration of bleomycin is not a treatment pr
otocol without risks or side effects, even if there is no fluid leakage int
o the cerebrospinal fluid. Although this is known to be an effective treatm
ent for cystic craniopharyngiomas, previous reports cannot be used to estab
lish a standard treatment method, and more research is needed to yield a sa
fer effective protocol.